CareFirst Specialty Pharmacy

What CareFirst Specialty Pharmacy does

CareFirst Specialty Pharmacy is a PCAB Gold-accredited compounding pharmacy headquartered in Mount Laurel, New Jersey (founded 2014; 51-100 employees), preparing custom, patient-specific medications for both human and veterinary patients across all 50 US states and the US Virgin Islands. Its core offering is made-to-order compounded prescriptions — never off-the-shelf — in dosage forms including transdermal gels, troches, chewies, lollipops, capsules, suspensions, topical creams, sublingual drops, and suppositories, with hypoallergenic excipient options (free of dyes, sugar, lactose, alcohol, gluten, corn, dairy, and soy). The pharmacy uses Mazerustar planetary mixing technology for content uniformity, adheres to USP <795> (non-sterile compounding) and <800> (hazardous drug handling), and validates formulations through independent testing at ARL Bio Pharma.

The product portfolio spans human therapeutic categories (HRT, custom T3/T4 thyroid, Low Dose Naltrexone (LDN), methylene blue, hair loss, dermatology, pain management, wound care, podiatry, dental) and veterinary categories (cardiology, diuretics, hormonal/endocrine, pain, seizure disorders), with transdermal and flavored formulations supporting animal-health dosing. The business model is transactional per-prescription: patients (or their prescribers via fax, phone, or e-prescribe NCPDP# 3151266) submit prescriptions, payment is collected before compounding begins, pricing varies by compound ($24.95 to over $140), and recurring refills flow through the FillMyRefills web portal and mobile app. GTM operates on twin motions: prescriber-driven partnerships (30,000+ active prescribers, B2B account management, white-label packaging options) and direct-to-consumer digital (SEO-optimized product pages, blog content marketing, newsletter, YouTube).

In FY 2025, CareFirst was acquired by Fagron NV, a Netherlands-headquartered global pharmaceutical compounding specialist, as part of Fagron's 12 strategic acquisitions across regions; it continues to operate as an independently marketed brand under the Fagron portfolio. Revenue, headcount growth, and detailed financials are not disclosed, but operating status is confirmed active.

Name

CareFirst Specialty Pharmacy

Legal name

CareFirst Specialty Pharmacy, LLC

Website

https://cfspharmacy.pharmacy

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

CareFirst Specialty Pharmacy is a PCAB Gold-accredited compounding pharmacy that prepares custom, patient-specific medications for human and veterinary patients across all 50 US states. It serves 30,000+ prescribers via prescription-driven and direct-to-consumer channels.

Ownership category

akta.pro rank

Product category

Compounding Pharmacy Services

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmacies and Drug Retailers (45611), Veterinary Services (54194)

SIC

Pharmaceutical Preparations (2834), Retail-Drug Stores And Proprietary Stores (5912)

akta.pro primary industry

Compounding Pharmacies (Veterinary) (HLAMAIAD)

Keywords

• Compounding pharmacy services
• Human medication compounding
• Veterinary medication compounding
• Hormone replacement therapy
• Specialty prescription fulfillment

Headquarters

HQ city

Cinnaminson

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Compounded Prescription Medications: CareFirst Specialty Pharmacy generates revenue by compounding and dispensing patient-specific prescription medications. All prescriptions are made-to-order (never off-the-shelf), with payment collected before compounding begins. The pharmacy prepares custom medications in precise strengths and dosage forms based on prescriber orders, serving both human patients and veterinary patients. Pricing varies by compound, ranging from approximately $24.95 to over $100 per preparation.
2. Prescription Refills and Recurring Orders: The pharmacy generates recurring revenue through its FillMyRefills online portal, allowing patients to manage and submit prescription refills. The made-to-order model means patients return for each new prescription cycle, creating repeat business. Shipping charges for various delivery speeds (Standard $4.95 to Next Day Air Ice $120) also contribute to revenue.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

CareFirst Specialty Pharmacy compounds patient-specific prescription medications for both human and veterinary use, preparing customized strengths, dosage forms, and allergen-free formulations based on prescriber orders. The pharmacy offers therapeutic categories including hormone replacement therapy, thyroid, methylene blue, low dose naltrexone, hair loss, and skin care for humans, plus cardiology, hormonal/endocrine, pain, seizure, and diuretic compounds for animals. Services are supported by e-prescribe, fax/phone routing, the FillMyRefills portal, and nationwide shipping to all 50 U.S. states.

Product overview

CareFirst Specialty Pharmacy is a nationally accredited compounding pharmacy operating as a single integrated platform offering human and veterinary medication compounding services. The core offering consists of customized, patient-specific medications prepared to order using state-of-the-art equipment and USP-compliant processes. For human medicine, key therapeutic products include Hormone Replacement Therapy (HRT), Thyroid preparations, Methylene Blue, Low Dose Naltrexone (LDN), Hair Loss formulations, and Skin Care products. For veterinary medicine, the portfolio includes Cardiology/Cardiovascular, Diuretics, Hormonal Endocrine, Pain Medication, and Seizure Disorder compounds. Additional services include Prescriber Partnership (e-prescribe, fax routing) and nationwide prescription shipping. The company serves patients across all 50 U.S. states with accreditations from PCAB, ACHC, NABP, PCCA, and IACP.

Differentiator

Problem solved

Functional benefit

Products and services

• Human Medicine Compounding Customized compounded medications for human patients across therapeutic areas including hormone replacement therapy, thyroid disorders, pain management, methylene blue, low dose naltrexone, hair loss, skin care, dermatology, wound care, podiatry, and dental compounding. Preparations are made to order with patient-specific dosing, strengths, and dosage forms.
• Veterinary Medicine Compounding Customized compounded medications for veterinary patients including pets, horses, and exotic animals. Provides species-specific dosing, palatable flavors, and alternative delivery forms such as transdermal gels, flavored suspensions, soft chews, and capsules for conditions including cardiology, pain, hormonal/endocrine disorders, seizures, and digestive issues.
• Hormone Replacement Therapy (HRT) Compounding Compounded hormone preparations using plant-based natural hormones including estrogen, progesterone, testosterone, DHEA, estriol, and estradiol in various dosage forms (creams, capsules, troches, vaginal suppositories) tailored to individual patient symptoms for menopause, andropause, or hormonal decline.
• Thyroid Compounding Custom thyroid preparations with specific T3/T4 ratios, hypoallergenic excipients, and options for desiccated porcine thyroid or pure hormone (levothyroxine T4, liothyronine T3) for patients with hypothyroidism or thyroid cancer whose symptoms are not well-controlled by commercial formulations.
• Methylene Blue Compounding Compounded methylene blue formulations for treatment of methemoglobinemia, neurological/cognitive support, mood management, mitochondrial health, and antimicrobial applications, available in multiple capsule strengths.
• Low Dose Naltrexone (LDN) Compounding Compounded Low Dose Naltrexone formulations (0.5mg-6mg) in immediate release tablets, capsules, sublingual tablets, oral suspensions, topical creams, and ultra-low dose variants for immune modulation and anti-inflammatory effects in autoimmune conditions, chronic pain, and fibromyalgia.
• Hair Loss Compounding Custom hair loss formulations combining actives such as minoxidil, finasteride, dutasteride, latanoprost, tretinoin, azelaic acid, progesterone, and biotin in topical solutions, foams, shampoos, and creams for androgenetic alopecia and other hair loss conditions.
• Skin Care Compounding Compounded prescription skin care medications using cosmeceutical and prescription actives for anti-aging, acne, eczema, psoriasis, vitiligo depigmentation, wound care, and dermatological conditions, with formulations that can include tretinoin, clindamycin, fluorouracil, and other personalized ingredients.
• Veterinary Cardiology / Heart / Blood Pressure Compounding Compounded veterinary cardiovascular medications including amlodipine, benazepril, atenolol, furosemide, and aminophylline in flavored suspensions, soft chews, and transdermal formulations for pets with heart conditions, hypertension, and cardiac arrhythmias.
• Prescriber Partnership Services Partner services for healthcare providers including e-prescribe (ERX) integration, fax and phone prescription submission, online prescriber forms, and dedicated account support for routing patient prescriptions to the compounding pharmacy.
• Prescription Shipping Services Nationwide prescription delivery to all 50 U.S. states with multiple shipping options including standard, priority, overnight, and temperature-controlled (ICE) shipping for compounded medications.

Quantifiable outcome

• Serves 30,000+ prescribing healthcare providers across all 50 US states
• +1 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature4 records

Partnerships

Five partnerships are on record, tiered major and core.

• Fagron NVmajorOthersFagron NV, a global pharmaceutical compounding specialist headquartered in the Netherlands, acquired CareFirst Specialty Pharmacy in FY 2025 as part of 12 strategic acquisitions across all regions. Fagron reported total FY 2025 revenue of €952.2 million with record free cash flow of €125.9 million. This acquisition positions CareFirst under the Fagron corporate umbrella, though CareFirst continues to operate as an independently marketed brand.
• ARL Labs (Analytical Resource Lab / ARL Bio Pharma)coreTechnology or IntegrationARL Labs serves as CareFirst Specialty Pharmacy's independent lab partner, providing external quality validation and testing for compounded formulations. This independent testing relationship supports the pharmacy's quality assurance and regulatory compliance objectives.
• PCCA (Professional Compounding Centers of America)coreStrategic or Co-development PartnerCareFirst Specialty Pharmacy is a member of PCCA, receiving ongoing training, education, and access to compounding resources, formulations, and best practices. As a PCCA member, the pharmacy continually receives up-to-date training in compounding techniques and formulations.
• ACHC (Accreditation Commission for Health Care)coreStrategic or Co-development PartnerACHC conducts on-site accreditation surveys and reviews organizational structure, policies and procedures, and compliance with state and federal laws for CareFirst Specialty Pharmacy. PCAB accreditation is administered through ACHC.
• NABP (National Association of Boards of Pharmacy)coreStrategic or Co-development PartnerNABP verifies CareFirst Specialty Pharmacy as a legitimate online pharmacy through its .Pharmacy Website Verification Program. This partnership involves compliance with NABP patient-safety standards and verification of pharmacy licensing and operations.

Scale indicators5 records

Recent moves5 records

Expansion highlights6 records

Direct peers

• Wedgewood Pharmacy: One of the largest veterinary compounding pharmacies in the US, serving veterinarians, pet owners, and exotic animal practitioners with custom dosage forms and flavors. Direct competitor to CareFirst's veterinary compounding line across species and therapeutic categories.
• Stokes Pharmacy: PCAB-accredited compounding pharmacy offering both human and veterinary preparations with a national mail-order footprint. Comparable to CareFirst in product breadth, licensing scope, and prescriber-driven model.
• Avrio Pharmacy: Specialty compounding pharmacy focused on personalized hormone, thyroid, and wellness formulations with a strong prescriber partnership model. Directly comparable to CareFirst's HRT, thyroid, and bioidentical-hormone product lines.
• Apothecary Shoppe / Apothécare (RXLTC): Mid-market PCAB-accredited compounding pharmacy offering custom human and veterinary preparations via mail-order. Operates a similar B2B prescriber partnership and refill-driven revenue model as CareFirst.
• Curexa Compounding Pharmacy: PCAB-accredited compounding pharmacy shipping custom medications nationwide with emphasis on hormone, dermatology, and pediatric formulations. Comparable specialty formulary, licensing footprint, and DTC/prescriber GTM.

Broad incumbents

• Fagron NV (parent / portfolio peer): Global leader in pharmaceutical compounding with €952M FY 2025 revenue across 12 acquired brands including CareFirst. As the parent company it is both an internal peer (its other compounding subsidiaries compete with CareFirst) and a strategic incumbent benchmarking target.
• Walgreens Specialty Pharmacy: National retail pharmacy operator with a specialty/compounding arm serving high-touch prescriptions through thousands of locations. Broad incumbent offering overlapping (but not specialist) compounding capability across chronic and specialty therapies.
• CVS Specialty / Caremark: Largest US retail pharmacy chain with a specialty pharmacy unit and PBM that influences reimbursement for compounded medications. Competes with CareFirst indirectly via prescription routing and formulary decisions.

Emerging players

• Hims & Hers Health: Direct-to-consumer digital health platform offering personalized prescription treatments including hair loss, skincare, and hormone therapy with its own pharmacy infrastructure. Partial overlap with CareFirst on hair loss, HRT, and skin care compounded SKUs.
• Ro / Roman: Digital telehealth and pharmacy operator in men's and women's health, including compounded hormone and wellness offerings. Emerging player competing for the same consumer and prescriber mindshare in HRT/thyroid/wellness that CareFirst targets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/cfspharmacy
• Facebookfacebook.com/cfspharmacy

Compliance11 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CareFirst Specialty Pharmacy